跳至主要内容
临床试验/NCT06185140
NCT06185140尚未招募不适用

Effects of Rehabilitation Programme on Respiratory Function in Patients with Acquired and Intervened Congenital Heart Disease: a Randomized Controlled Trial

University of Salamanca0 个研究点目标入组 26 人开始时间: 2025年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
26
主要终点
Assessment of respiratory function/spirometry

研究概览

简要总结

Congenital heart defects (CHDs) are heart malformations that occur before birth, and they represent one of the leading causes of neonatal morbidity and mortality. they occur in approximately 1% of newborns and are associated with high morbidity and mortality rates. The etiology of these cardiac anomalies is mostly unknown. around 70-80% of cases are generated by the involvement of multiple affected genes combined with an environmental trigger that, when acting on a susceptible individual, promotes the expression of the damaged genome. maternal diseases during pregnancy or exposure to teratogenic substances are also implicated in the etiology.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

The study evaluator will not know the assignment of participants.

入排标准

年龄范围
18 Years 至 25 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Pediatric patients with a history of cardiac transplantation or acquired congenital heart disease who have undergone at least one interventional procedure or surgical intervention at least 6 months before the start of the program in a state of clinical stability, hemodynamic stability, and ECG stability. They should have residual hemodynamic defects of sufficient severity that potentially restrict participation, and their perception of fragility may be influenced by the social, family, school environment, or by the patient themselves.
  • Children aged 6-15 years at the start of the study.
  • Children with maximum predicted oxygen consumption (VO2 max) values <80%, as measured in ergospirometry 6 months before the start of the intervention program.
  • Patients for whom consultation with a pediatric cardiology specialist and pediatric rehabilitation specialist has not revealed contraindications for exercise.
  • Children and their legal representatives should have provided informed consent and the ability to travel to the hospital center for in-person intervention.

排除标准

  • Patients with acute, inflammatory, or infectious health conditions that could pose a risk to them during the course of the program.
  • Patients who have undergone at least one interventional procedure or surgical intervention within a period of less than 6 months before the start of the study.

结局指标

主要结局

Assessment of respiratory function/spirometry

时间窗: Baseline and immediately after the intervention

Spirometry is the study of choice in pulmonary function laboratories. The parameters it measures are the volume of air that the child breathes in or out in absolute value or related to time, and is shown in the volume/time curve. The most useful functional parameters obtained after spirometry are forced vital capacity (FVC), forced expiratory volume in the first second (FEV1), PEF and the FEV1 /FVC ratio

次要结局

  • Functional capacity(Baseline and immediately after the intervention)
  • Assessment of the respiratory musculature(Baseline and immediately after the intervention)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Juan Luis Sanchez Gonzalez

Principal Investigator

University of Salamanca

相似试验